SureTrader Advertisement
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

6:01AM Compugen announces results showing its CGEN-15001T drug

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 422
Posts 22,038
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program "PR Newswire (US)" - 6/22/2016 7:09:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/22/2016 7:02:52 AM
Compugen to Present at JMP Securities Life Sciences Conference in New York "PR Newswire (US)" - 6/15/2016 7:00:00 AM
Compugen to Present at the Jefferies Global Healthcare Conference in New York "PR Newswire (US)" - 5/23/2016 7:00:00 AM
Compugen to Present at the Oppenheimer Annual Israeli Conference in Tel Aviv "PR Newswire (US)" - 5/16/2016 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/10/2016 7:05:21 AM
Compugen Ltd. Reports First Quarter 2016 Financial Results "PR Newswire (US)" - 5/10/2016 7:01:00 AM
Steven Holtzman Joins Compugen as Strategic Business Advisor "PR Newswire (US)" - 5/10/2016 6:45:00 AM
Compugen First Quarter 2016 Conference Call and Webcast Scheduled for Tuesday, May 10, 2016 at 10:00 AM ET "PR Newswire (US)" - 4/27/2016 7:15:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 4/20/2016 7:13:20 AM
Compugen Achieves Preclinical Milestone in Cancer Immunotherapy Collaboration With Bayer "PR Newswire (US)" - 4/18/2016 7:14:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 4/18/2016 7:08:15 AM
Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director at Compugen USA, Inc. "PR Newswire (US)" - 4/6/2016 7:00:00 AM
Compugen to Present at the Jefferies Immuno-Oncology Summit in Boston "PR Newswire (US)" - 3/28/2016 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 3/8/2016 7:01:58 AM
Compugen Presents Results for CGEN-15029 Immuno-Oncology Therapeutic Program "PR Newswire (US)" - 2/29/2016 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/9/2016 7:11:29 AM
Compugen Ltd. Reports Fourth Quarter and Calendar 2015 Results "PR Newswire (US)" - 2/9/2016 7:09:00 AM
Compugen Fourth Quarter and Yearend 2015 Conference Call Scheduled for Tuesday, February 9, 2016 at 10:00 AM EST "PR Newswire (US)" - 1/26/2016 7:00:00 AM
Compugen Achieves Third Preclinical Milestone in Cancer Immunotherapy Collaboration with Bayer "Business Wire" - 12/11/2015 9:06:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/11/2015 8:31:41 AM
Compugen to Present at the Oppenheimer Healthcare Conference in New York "Business Wire" - 11/24/2015 7:00:00 AM
Compugen to Present at Jefferies 2015 Global Healthcare Conference in London "Business Wire" - 11/12/2015 7:00:00 AM
Compugen Presents Translational Study Results Supporting CGEN-15001 for the Treatment of Rheumatoid Arthritis "Business Wire" - 11/9/2015 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/3/2015 8:02:40 AM
surf1944   Thursday, 02/02/12 10:57:15 AM
Re: surf1944 post# 109
Post # of 146 
6:01AM Compugen announces results showing its CGEN-15001T drug may have potential for cancer immunotherapy (CGEN) 5.30 : Co announced results demonstrating the therapeutic potential of CGEN-15001T as a drug target for treatment of multiple cancers by means of monoclonal antibody ("mAb") therapy. These results indicate that CGEN-15001T is expressed on numerous types of cancer, such as carcinomas, sarcomas, melanoma and hematological cancers as well as on immune cells. These findings, together with previous results supporting its active immunomodulatory effect, 'strongly support CGEN-15001T's potential as a powerful drug target for treatment of various solid and hematological cancers, an area of great interest to the pharmaceutical industry.'


surf's up......crikey



SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist